Outset Medical, Inc.
Outset Medical, Inc. designs and commercializes the Tablo hemodialysis system, a dialysis platform used in acute care, post-acute care, and home settings. The company is based in the United States and sells a combination of capital equipment, consumables, service agreements, and related support services.
Tilikausi 2025 · muutos edellisvuodesta
Kehitys 2020–2025
Liiketoiminta
Osuus liikevaihdostaTablo dialysis machines and related accessories sold to providers and care settings.
Recurring cartridge and other disposable supplies used with Tablo systems.
Maintenance, repair, training, and software-enabled support contracts.
Operating lease revenue and shipping/handling or other ancillary items.
Tuotteet
Raportoitu · osuus liikevaihdosta- Consumables Product45,3 %
- Service and Other Revenue29,0 %
- Consoles Product25,7 %
Lähde: 10-K FY2025, yhtiön tuotelinjoittain raportoima liikevaihto (SEC XBRL). Osuudet on laskettu näytetyistä riveistä ja ne summautuvat 100 %:iin.
Asiakkaat
Outset Medical sells primarily to hospitals, health systems, and dialysis providers that use Tablo for acute and post-acute dialysis care. It also serves home hemodialysis patients through provider and clinic channels, with the provider typically making the purchasing decision and supporting patient training and deployment.
Buy Tablo consoles, consumables, and support to run inpatient dialysis programs and insource services.
Use Tablo to expand fleet utilization, support outpatient and acute workflows, and manage dialysis delivery.
Adopt Tablo for home therapy because of ease of use, training simplicity, and patient support needs.
Skilled nursing facilities and LTACHs buy Tablo to support dialysis access in lower-acuity settings.
Strategia
Outset Medical’s strategy is to expand Tablo adoption in acute care, post-acute care, and home hemodialysis by proving clinical, operational, and economic benefits versus traditional dialysis delivery. It also aims to deepen utilization at existing customers through fleet expansion, service infrastructure, and training while broadening the installed base through direct sales.
Broader adoption increases installed base, consumables pull-through, and recurring service revenue.
Higher utilization improves revenue per installed system and deepens customer relationships.
Dialysis equipment adoption depends on training, field service, and reliable support.
Maantiede
The business is centered in the United States, where product and service revenue is generated primarily through direct sales. The company also notes competition and dialysis market activity in Europe and Asia, but its commercial footprint and customer coverage are mainly U.S.-based.
Riskit
Outset Medical is exposed to concentration risk because revenue is tied to a single main product platform and a limited number of customers. The business also faces manufacturing, supply chain, and tariff risk because a significant portion of operations is outside the United States, while customer budget pressure and staffing shortages can slow purchasing and installation cycles.
- Single-product dependenceVaikutus: KorkeaTodennäköisyys: Korkea
The business is heavily reliant on Tablo, so adoption or performance issues would affect revenue broadly.
Kohdistuu: Tablo platform and related consumables/services
- Customer concentrationVaikutus: KorkeaTodennäköisyys: Kohtalainen
A limited number of customers can cause volatile revenue if orders shift or contracts are lost.
Kohdistuu: Largest customer was 15% of 2025 revenue
- Manufacturing and supply chain disruptionVaikutus: KorkeaTodennäköisyys: Kohtalainen
International operations and third-party suppliers can be affected by labor, logistics, or trade issues.
Kohdistuu: Manufacturing outside the United States; single-source suppliers
- Customer budget and staffing pressureVaikutus: KeskitasoTodennäköisyys: Korkea
Hospitals and providers may delay capital spending and installations when labor or budgets are tight.
Kohdistuu: Acute care and health system customers
- Competitive pressureVaikutus: KeskitasoTodennäköisyys: Kohtalainen
Larger dialysis companies have greater resources and installed relationships, which can slow market share gains.
Kohdistuu
Kirjanpito
Harkinnanvaraiset erätRevenue comes from upfront product sales plus recurring consumables and services, so timing differs by stream.
Vaikutus: Affects quarterly comparability and the mix between product and recurring revenue
Manufacturing and supply planning can create excess stock or obsolescence risk.
Vaikutus: Can materially affect cost of product revenue
Dialysis equipment support obligations require estimates of future repair and replacement costs.
Vaikutus: Affects gross margin and operating expense timing
Limited console operating leases require separate revenue and lease accounting treatment.
Vaikutus: Can shift revenue recognition over the lease term
Samankaltaisia listattuja yhtiöitä
Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.
Rockwell Medical, Inc
RMTI · Pharmaceutical Preparations
Owlet, Inc.
OWLT · Measuring & Controlling Devices, NEC
iRadimed Corporation
IRMD · Surgical & Medical Instruments & Apparatus
IRADIMED Corp designs and sells MRI-compatible medical devices used inside scanner rooms, centered on infusion pumps, patient vital signs monitoring systems, and related disposables and service.
Haemonetics Corporation
HAE · Surgical & Medical Instruments & Apparatus
Haemonetics is a U.S.-based medical technology company that designs and sells systems used to collect, process, and manage blood and plasma.
Adagio Medical Holdings, Inc.
ADGM · Surgical & Medical Instruments & Apparatus
Option Care Health, Inc.
OPCH · Services-Home Health Care Services
Option Care Health is a U.S.-based provider of home and alternate-site infusion services delivered through a national network of locations.
Päivitetty: 24.9.2026